Apolipoprotein C-II deficiency presenting as a lipid encephalopathy in infancy

Annals of Neurology

Volumn 53, Issue 6, 2003, Pages 807-810

  Wilson, Callum J ^a   Oliva, Claudio Priore ^b   Maggi, Franco ^c   Catapano, Alberico L ^c   Calandra, Sebastiano ^b  

^a STARSHIP CHILDREN S HOSPITAL   (New Zealand)

^b UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

^c UNIVERSITY OF MILAN   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; APOLIPOPROTEIN C2; APOLIPOPROTEIN C3; CHOLESTEROL; CHYLOMICRON; GENOMIC DNA; HIGH DENSITY LIPOPROTEIN; LIPOPROTEIN LIPASE; TRIACYLGLYCEROL;

ARTICLE; ARTIFICIAL MILK; BRAIN; BRAIN ATROPHY; BRAIN DISEASE; CASE REPORT; CHILD DEATH; CHOLESTEROL BLOOD LEVEL; CLINICAL FEATURE; CONSANGUINITY; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE SEVERITY; DNA SEQUENCE; FAMILY HISTORY; FEEDING DISORDER; FEMALE; GENETIC ANALYSIS; HEPATOSPLENOMEGALY; HOMOZYGOSITY; HUMAN; HYPERLIPOPROTEINEMIA TYPE 1; IMAGE ANALYSIS; INFANT; LETHARGY; LIPID ANALYSIS; LIPID BLOOD LEVEL; LIPID STORAGE; LIPOPROTEIN DEFICIENCY; LOWER RESPIRATORY TRACT INFECTION; MACROCEPHALY; MENTAL DEFICIENCY; NEUROLOGIC DISEASE; NEW ZEALAND; NEWBORN DEATH; NUCLEAR MAGNETIC RESONANCE IMAGING; PHENOTYPE; POINT MUTATION; PRESCHOOL CHILD; PRIORITY JOURNAL; RELATIVE; RETINA DETACHMENT; SIBLING; TACHYPNEA; TREATMENT OUTCOME; TRIACYLGLYCEROL BLOOD LEVEL; URINARY TRACT INFECTION;

APOLIPOPROTEIN C-II; APOLIPOPROTEINS C; BRAIN; DIAGNOSIS, DIFFERENTIAL; DNA MUTATIONAL ANALYSIS; FEMALE; HUMANS; HYPERLIPOPROTEINEMIA TYPE I; INFANT; INFANT, NEWBORN; MAGNETIC RESONANCE IMAGING; POINT MUTATION; PROMOTER REGIONS (GENETICS);

EID: 0038443025     PISSN: 03645134     EISSN: None     Source Type: Journal    
DOI: 10.1002/ana.10598     Document Type: Article

References (17)

1. Santamarina-Fojo S, Dugi KA. Structure, function and role of lipoprotein lipase in lipoprotein metabolism. Curr Opin Lipidol 1994;5:117-125.
2. Brunzell JD, Deeb SS. Familial lipoprotein lipase deficiency, Apo C-II deficiency and hepatic lipase deficiency. In: Scriver CR, Beaudet AL, Valle D, Sly WS, eds. The metabolic and molecular basis of inherited disease. 8th ed, New York: McGram-Hill, 2002:2789-2816.
3. Havel RJ, Gorden RS Jr. Idiopathic hyperlipidemia: metabolic studies in an affected family. J Clin Invest 1960;39:1777-1790.
4. Breckenridge WC, Little JA, Steiner G, et al. Hypertriglyceridemia associated with a deficiency of apolipoprotein C-II N Engl J. Med 1978;298:1265-1273.
5. Brunzell JD. Lipoprotein lipase deficiency and other causes of the chylomicronemia syndrome. In: Scriver CR, Beaudet AL, Valle D, Sly WS, eds. The metabolic and molecular basis of inherited disease. 6th ed. New York: McCraw-Hill, 1989:1165-1180.
6. Santamarina-Fojo S. The familial chylomicronemia syndrome. Endocrinol Metab Clin North Am 1998;27:551-567.
7. Reina M., Brunzell JD, Deeb SS. Molecular basis of familial chylomicronemia: mutations in the lipoprotein lipase and apolipoprotein C-II gene. J Lipid Res 1992;33:1823-1832.
8. Capurso A, Pace I., Bonomo I., et al. New case of apoprotein C-II deficiency. Lancet 1980;1:268.
9. Stalenhoef AF, Casparie AF, Demacker PN, et al. Combined deficiency of apolipoprotein C-II and lipoprotein lipase in familial hyperchylomicronemia. Metabolism 1981;30:919-926.
10. Nijmegen) of a patient with a deficiency of apolipoprotein C-II. J Biol Chem 1988;263:17913-17916.
11. Olbia). Clin Genet 2000;57:140-147.
12. Wei C-F, Tsao Y-K, Robberson DL, et al. The structure of the human apolipoprotein C-II gene. J Biol Chem. 1985;260:15211-15221.
13. Black VD, Lubchenco LO, Luckey DW, et al. Developmental and neurologic sequelae of neonatal hyperviscosity syndrome. Pediatrics 1982;69:426-431.
14. Shah CK, Sharma S, Walsh A. Lipemia retinalis. Ophthalmic Surg Lasers 2001;32:7-78.
15. Cheng Q, Blackett P, Jackson KW, et al. C-terminal domain of apolipoprotein CII as both activator and competitive inhibitor of lipoprotein lipase. Biochem J 1990;269:403-407.
16. Olivecrona G, Beisiegel U. Lipid binding of apolipoprotein CII is required for stimulation of lipoprotein lipase activity against apolipoprotein C-II deficient chylomicrons. Arterioscl Thromb Vasc Biol 1997;17:1545-1549.
17. Padova gene in a patient with apolipoprotein C-II deficiency. J Clin Invest 1989;84:1215-1219.